HEMUNOZ Trademark

Trademark Overview

On Thursday, October 9, 2014, a trademark application was filed for HEMUNOZ with the United States Patent and Trademark Office. The USPTO has given the HEMUNOZ trademark a serial number of 86419359. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 9, 2018. This trademark is owned by Novartis AG. The HEMUNOZ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely analgesics, anti-inflammatory drugs and antipyretics
hemunoz

General Information

Serial Number86419359
Word MarkHEMUNOZ
Filing DateThursday, October 9, 2014
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 9, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 6, 2015

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely analgesics, anti-inflammatory drugs and antipyretics
Translation of Words in MarkThe wording "HEMUNOZ" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, October 16, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel
CH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events

Event DateEvent Description
Monday, April 9, 2018ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, April 9, 2018ABANDONMENT - NO USE STATEMENT FILED
Wednesday, September 6, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 5, 2017EXTENSION 5 GRANTED
Friday, September 1, 2017EXTENSION 5 FILED
Friday, September 1, 2017TEAS EXTENSION RECEIVED
Saturday, March 4, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 2, 2017EXTENSION 4 GRANTED
Thursday, March 2, 2017EXTENSION 4 FILED
Thursday, March 2, 2017TEAS EXTENSION RECEIVED
Thursday, September 8, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 7, 2016EXTENSION 3 GRANTED
Thursday, September 1, 2016EXTENSION 3 FILED
Thursday, September 1, 2016TEAS EXTENSION RECEIVED
Friday, April 1, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 31, 2016EXTENSION 2 GRANTED
Monday, February 29, 2016EXTENSION 2 FILED
Thursday, March 31, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, February 29, 2016TEAS EXTENSION RECEIVED
Tuesday, September 1, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 28, 2015EXTENSION 1 GRANTED
Friday, August 28, 2015EXTENSION 1 FILED
Friday, August 28, 2015TEAS EXTENSION RECEIVED
Tuesday, March 3, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 6, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 6, 2015PUBLISHED FOR OPPOSITION
Wednesday, December 17, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 25, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, November 21, 2014ASSIGNED TO EXAMINER
Thursday, October 16, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, October 13, 2014NEW APPLICATION ENTERED IN TRAM

Related Keywords

hemunoz inflammatory drugs antipyretics anti analgesics preparations namely pharmaceutical